Pharmacoeconomics-Open

Scope & Guideline

Fostering Innovation in Health Economics

Introduction

Explore the comprehensive scope of Pharmacoeconomics-Open through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Pharmacoeconomics-Open in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2509-4262
PublisherSPRINGER INT PUBL AG
Support Open AccessYes
CountrySwitzerland
TypeJournal
Convergefrom 2017 to 2024
AbbreviationPHARMACOECON-OPEN / Pharmacoecon.-Open
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGEWERBESTRASSE 11, CHAM CH-6330, SWITZERLAND

Aims and Scopes

Pharmacoeconomics-Open is dedicated to advancing the field of pharmacoeconomics and health economics through rigorous analysis and evaluation of healthcare interventions. The journal emphasizes the importance of economic evaluations in informing healthcare decision-making and policy formulation.
  1. Cost-Effectiveness Analysis (CEA):
    The journal publishes extensive research on cost-effectiveness analyses of various healthcare interventions, including pharmaceuticals, medical devices, and treatment protocols, providing a comprehensive understanding of their economic value.
  2. Health Technology Assessment (HTA):
    Pharmacoeconomics-Open focuses on health technology assessments that evaluate the clinical efficacy, safety, and economic implications of new treatments and technologies, guiding stakeholders in healthcare decision-making.
  3. Budget Impact Analysis (BIA):
    The journal includes studies on budget impact analyses, evaluating the financial implications of adopting new therapies or technologies within specific healthcare systems, aiding in resource allocation and policy planning.
  4. Patient-Centered Outcomes:
    Research highlighting patient-reported outcomes and quality of life assessments is central to the journal's scope, emphasizing the importance of patient perspectives in evaluating healthcare interventions.
  5. Methodological Innovations in Economic Evaluation:
    Pharmacoeconomics-Open encourages submissions that explore new methodologies in economic evaluation, including modeling techniques and statistical approaches, to enhance the rigor and applicability of pharmacoeconomic studies.
Pharmacoeconomics-Open is witnessing emerging themes that reflect the evolving landscape of healthcare economics and the increasing complexity of healthcare interventions. These trends highlight the journal's responsiveness to contemporary challenges and innovations in the field.
  1. Integration of Artificial Intelligence (AI):
    Recent publications emphasize the role of AI in automating health economic modeling and decision-making processes, showcasing innovative applications that enhance efficiency and accuracy in economic evaluations.
  2. Real-World Evidence (RWE):
    There is a growing trend towards incorporating real-world evidence in economic evaluations, with studies focusing on the effectiveness and cost implications of interventions in routine clinical practice, rather than controlled trial settings.
  3. Value-Based Healthcare Models:
    Emerging research emphasizes value-based healthcare approaches that assess treatments based on their outcomes relative to costs, reflecting a shift in focus from volume-based care to value-driven systems.
  4. Patient-Centered and Multi-Criteria Decision Analysis:
    An increasing number of studies are employing multi-criteria decision analysis (MCDA) frameworks that incorporate diverse stakeholder preferences, including patient values, in the evaluation of healthcare interventions.
  5. Global Health Economics:
    The journal is seeing a rise in submissions addressing global health economics, particularly in low- and middle-income countries, highlighting unique challenges and opportunities in these contexts.

Declining or Waning

While Pharmacoeconomics-Open continues to thrive in many areas, certain themes appear to be waning in prominence over the recent years. This decline may reflect shifts in research focus or changing priorities in healthcare economics.
  1. Traditional Cost-Utility Analysis:
    There is a noticeable decline in the frequency of traditional cost-utility analyses focusing solely on generic health states, as researchers increasingly adopt more nuanced approaches that incorporate broader patient-reported outcomes.
  2. Single-Condition Focused Studies:
    Research solely centered on specific diseases or conditions, such as individual cancers or chronic illnesses, is becoming less prevalent, with a shift towards studies that consider broader healthcare systems and multiple conditions.
  3. Static Economic Models:
    The use of static economic models that do not account for real-world variability and long-term outcomes is decreasing, as there is a growing preference for dynamic modeling approaches that reflect changing patient populations and treatment landscapes.

Similar Journals

PHARMACOECONOMICS

Advancing understanding of drug costs and health outcomes.
Publisher: ADIS INT LTDISSN: 1170-7690Frequency: 12 issues/year

PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

CLINICAL THERAPEUTICS

Advancing pharmacological innovation for better patient outcomes.
Publisher: ELSEVIERISSN: 0149-2918Frequency: 12 issues/year

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

Global & Regional Health Technology Assessment

Innovating health solutions through critical assessment.
Publisher: ABOUTSCIENCE SRLISSN: 2284-2403Frequency: 1 issue/year

Global & Regional Health Technology Assessment (ISSN: 2284-2403; E-ISSN: 2283-5733) is an esteemed open-access journal published by ABOUTSCIENCE SRL, dedicated to the dissemination of research in the field of health technology assessment on a global and regional scale. Since its inception in 2014, this journal has focused on the critical evaluation of health technologies, providing invaluable insights into their efficacy, cost-effectiveness, and impact on healthcare systems. With an increasing emphasis on public health and policy implications, the journal encourages interdisciplinary research that bridges gaps between technological innovations and health outcomes. Despite its relatively recent establishment, it has made significant inroads with Scopus rankings reflecting the growing importance of health technology assessment in global health discourse. The journal welcomes contributions from researchers, professionals, and students, inviting them to engage in discussions that shape the future of health technology, with the aim of informing stakeholders and policymakers worldwide.

Expert Review of Pharmacoeconomics & Outcomes Research

Elevating Standards in Pharmacoeconomic Research
Publisher: TAYLOR & FRANCIS LTDISSN: 1473-7167Frequency: 6 issues/year

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

Farmeconomia-Health Economics and Therapeutic Pathways

Innovative insights at the intersection of health and economics.
Publisher: SEED MEDICAL PUBLISHERSISSN: 1721-6915Frequency: 1 issue/year

Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.

BMC HEALTH SERVICES RESEARCH

Fostering collaboration for a healthier tomorrow.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Health Services Research is a leading open-access journal dedicated to advancing the field of health policy and services research. Published by BMC since 2001 and based in the United Kingdom, this journal has established itself as an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of health care systems and policies. With an impressive 2023 Q1 ranking in the Health Policy category and a Scopus rank of 90/310, it clearly demonstrates its commitment to high-quality, impactful research. The journal's open-access model ensures that research findings are accessible to a global audience, promoting collaboration and innovation in health services. Spanning from 2001 to 2024, BMC Health Services Research is poised to remain at the forefront of health services research, making significant contributions to policy formulation and practice improvement in the healthcare sector.

Journal of Health Economics and Outcomes Research

Elevating healthcare efficiency through rigorous research.
Publisher: COLUMBIA DATA ANALYTICS, LLCISSN: 2327-2236Frequency: 1 issue/year

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.

American Economic Journal-Economic Policy

Exploring Evidence-Based Solutions in Economic Policy
Publisher: AMER ECONOMIC ASSOCISSN: 1945-7731Frequency: 4 issues/year

American Economic Journal - Economic Policy, published by the American Economic Association, stands at the forefront of economic research, focusing on significant policy implications and evidence-based evaluations. With an ISSN of 1945-7731 and an E-ISSN of 1945-774X, this esteemed journal has maintained its influence and credibility in the field since its inception in 2009. Ranked in the Q1 category for Economics, Econometrics and Finance and ranking #7 out of 288 in Scopus, it boasts a remarkable 97th percentile ranking, making it a premier source for cutting-edge research and policy discussion. The journal's rigorous peer-reviewed articles aim to bridge the gap between academic research and real-world economic policy, serving as an essential resource for researchers, professionals, and students who seek to engage with and contribute to the evolving landscape of economic policy. With open access options not currently available, readers are encouraged to subscribe or access articles through academic institutions for comprehensive insights into the economic challenges and innovations shaping our world.

ClinicoEconomics and Outcomes Research

Innovating Healthcare Decisions with Economic Insights
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6981Frequency: 1 issue/year

ClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!

International Journal of Healthcare Management

Advancing healthcare management through innovative research.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 2047-9700Frequency: 4 issues/year

The International Journal of Healthcare Management, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, stands as a crucial platform for the dissemination of innovative research and insights in the realm of healthcare management. With a focus on health policy, leadership, and management, this journal aims to bridge the gap between theory and practice, providing a valuable resource for researchers, professionals, and students alike. It boasts an impressive Q2 ranking in Leadership and Management and a Q3 ranking in Health Policy for 2023, highlighting its influence and relevance within the academic community. With an accessible ISSN of 2047-9700 and E-ISSN of 2047-9719, the journal features an array of peer-reviewed articles that promote the advancement of knowledge and best practices in healthcare settings. While currently not offered as open access, the journal publishes high-quality research that underscores the importance of effective management strategies in enhancing healthcare outcomes. Positioned in the United Kingdom, the journal continues to contribute significant knowledge and frameworks that guide healthcare leaders and policymakers in navigating the complexities of governance in health services.